Cardio Diagnostics Holdings, Inc. income statement

In fiscal 2025, Cardio Diagnostics Holdings, Inc. reported revenue of $14,825, down 57.5% on the year before, operating income of −$6.5m (a -43737.5% margin) and net income of −$6.5m, or −$3.71 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cardio Diagnostics Holdings, Inc.: income statement, annual
Fiscal year	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	1	1	17	35	15	14
Research and development	31	40	145	228	641	769
Selling and marketing	103	93	159	1,232	767	—
General and administrative	471	4,400	6,937	6,921	5,026	—
Operating income	−620	−4,548	−7,242	−8,366	−6,484	−6,458
Interest expense	—	—	6,735	19	15	12
Income before tax	−620	−4,661	−8,377	−8,383	−6,498	−6,470
Income tax	0	0	—	—	—	—
Net income	−620	−4,661	−8,377	−8,383	−6,498	−6,470
Diluted EPS	−$1.99	−$5.66	−$9.90	−$4.67	−$3.71	−$2.76
Diluted shares (average)	—	—	—	2m	2m	2m
EBITDA	−604	−4,532	−7,223	−8,346	−6,419	−6,457

US$ thousands unless shown otherwise. Fiscal quarters.

Cardio Diagnostics Holdings, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	7	5	1	7	3	4	3	5
Research and development	5	205	119	179	189	287	130	163
Selling, general and administrative	1,416	—	—	1,686	1,714	—	—	—
Selling and marketing	—	1,088	189	—	—	—	197	190
General and administrative	—	223	1,278	—	—	—	1,455	1,145
Operating income	−1,409	−1,516	−1,631	−1,679	−1,712	−1,463	−1,785	−1,498
Interest expense	4	3	5	5	3	2	3	3
Income before tax	−1,413	−1,519	−1,635	−1,683	−1,715	−1,465	−1,788	−1,501
Net income	−1,413	−1,519	−1,635	−1,683	−1,715	−1,465	−1,788	−1,501
Diluted EPS	−$1.73	−$0.28	−$0.97	−$0.97	−$0.98	−$0.80	−$0.63	−$0.51
EBITDA	−1,404	−1,511	−1,585	−1,670	−1,671	−1,514	−1,779	−1,493

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CDIO vs CUPR CDIO vs HSCS CDIO vs POAS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cardio Diagnostics Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cardio Diagnostics Holdings, Inc.